Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07032610Active Not Recruiting
Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents
Hepatitis AHepatitis A VirusVaccine-Preventable Diseases
PrincipalinvestigatorStart date: 2025-06-26
NCT06978621Phase 3Active Not Recruiting
Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV
Hepatitis AHepatitis A VirusVaccine-Preventable Diseases
PrincipalinvestigatorStart date: 2025-05-25
NCT06298708Phase 3Completed
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents
HAVHep AHepatitis A+1 more
PrincipalinvestigatorStart date: 2024-04-27

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Pediatrics, Faculty of Medicine, Chiang Mai University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Tavitiya Sudjaritruk, MD, PhD

Department of Pediatrics, Faculty of Medicine, Chiang Mai University

Similar
4 trials

Shared therapeutic areas:

Vaccine-Preventable DiseasesHepatitis AHepatitis A virus+2 more

Worked with same sponsors:

Chiang Mai UniversityFaculty of Medicine, Chiang Mai University
Collaborated on 3 trials
Similarity Score62%

Zitta B Harboe, MD, PhD

Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital - North Zealand

Related
1 trials

Shared therapeutic areas:

Vaccine-Preventable Diseases
Similarity Score6%

Joseph T Wu, PhD

The University of Hong Kong

Related
2 trials

Shared therapeutic areas:

Vaccine-Preventable Diseases
Similarity Score6%

Claus Bistrup, MD, PhD

Department of Nephrology, Odense University Hospital

Related
1 trials

Shared therapeutic areas:

Vaccine-Preventable Diseases
Similarity Score6%

Suk-Kyun Yang, M.D.

Asan Medical Center

Related
2 trials

Shared therapeutic areas:

Hepatitis A
Similarity Score6%

Nicole Stoffel, PhD

ETH Zurich

Related
3 trials

Shared therapeutic areas:

Vaccine-Preventable Diseases
Similarity Score6%

Pierre van Damme, MD

Universiteit Antwerpen

Related
2 trials

Shared therapeutic areas:

Hepatitis A
Similarity Score6%

Susanne D Nielsen, MD, DMSc

Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet

Related
1 trials

Shared therapeutic areas:

Vaccine-Preventable Diseases
Similarity Score6%

Henrik Birn, MD, PhD, DMSc

Department of Nephrology, Aarhus University Hospital

Related
1 trials

Shared therapeutic areas:

Vaccine-Preventable Diseases
Similarity Score6%

Frank Lee, MD

Frontage Clinical Services, Inc.

Related
5 trials

Shared therapeutic areas:

Vaccine-Preventable Diseases
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07032610PrincipalInvestigator

Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents

Hepatitis AHepatitis A VirusVaccine-Preventable Diseases
Active Not Recruiting
NCT06978621Phase 3PrincipalInvestigator

Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV

Hepatitis AHepatitis A VirusVaccine-Preventable Diseases
Active Not Recruiting
NCT06298708Phase 3PrincipalInvestigator

Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents

HAVHep AHepatitis A+1 more
Completed

All 3 trials loaded